PFE - iRobot Seagen Horizon gain amid Microsoft win in Activision case
2023-07-11 11:37:40 ET
- iRobot ( NASDAQ: IRBT ) jumped 1.5% after the Federal Trade Commission was defeated in its efforts to block Microsoft's ( MSFT ) $69 billion acquisition of Activision ( ATVI ).
- iRobot ( IRBT ) has been waiting to hear if the FTC will sue to block the robot maker's sale to Amazon ( AMZN ).
- Horizon Therapeutics ( NASDAQ: HZNP ), which was sued by the FTC in May over its planned sale to Amgen ( AMGN ), ticked up 0.2%.
- Seagen ( NASDAQ: SGEN ), which is waiting for the FTC to decide on its $43 billion planned sale to Pfizer ( PFE ), ticked up 0.6% . Pfizer last month agreed to pull and refile its merger notification with the FTC over its purchase of cancer drug maker Seagen ( SGEN ). A pull and refile resets the 30-day clock for the FTC to review the transaction.
- Developing story ...
For further details see:
iRobot, Seagen, Horizon gain amid Microsoft win in Activision case